As World Diabetes Day approaches, the accessibility of diabetes treatments remains a pressing issue. With rising cases of type 2 diabetes, particularly among younger populations, the need for affordable insulin pens is critical, especially in low-income countries. Recent corporate decisions further complicate access to essential medications.